Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use.

3815 pheelsevier Vaccine Vaccine PMC8433505 8433505 8433505 34521551 10.1016/j.vaccine.2021.08.097 Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use Palache Abraham a ⁎ Rockman Steven b c Taylor Beverly d Akcay Meral e Billington John K f Barbosa Paula g on behalf of the IFPMA Influenza Vaccine Supply (IFPMA IVS) task force a Consultant at Abbott, C.J. van Houtenlaan 36, 1381 CP Weesp, the Netherlands b Seqirus Ltd, 63 Poplar Road, Parkville, Victoria 3052, Australia c Department of Immunology and Microbiology, the University of Melbourne, Parkville, Victoria, Australia d Seqirus Vaccines, Renaissance Way, Speke, Liverpool L24 9JW, UK e Sanofi Pasteur, 2 Ave Pont Pasteur, Lyon 69007, France f GSK Vaccines, Av.

also in 11,005 other papers